Orange Book Blog

At the intersection of Patent and FDA Law

OBB News Briefs

Norvasc update: FDA Law Blog reports that the district court has extended FDA’s deadline and that Zydus has filed a new citizen petition.
Pharmalot reports on Barr Labs’ efforts to protect its Seasonale oral contraceptive from generic competition.
The WSJ Health Blog summarizes today’s front-page WSJ article on Amgen’s recent troubles.
The Business Standard and Times of India report that the Indian Health Minister has asked Novartis to withdraw its challenge of the Indian Patent Act, which follows India’s denial of a patent on Gleevec.
Follow-on biologics: new PhRMA statement; NYT article; WSJ editorial.